F. Verdun et al., TORSADES DE POINTE WITH SPIRAMYCIN AND ME QUITAZINE THERAPY - A CASE-REPORT, Archives des maladies du coeur et des vaisseaux, 90(1), 1997, pp. 103-106
The authors report the case of a 21 year old woman with a congenital l
ong Q7 syndrome who had several syncopal attacks at least one of which
was caused by torsades de pointe. This sudden complication was attrib
uted to the simultaenous prescription of Spiramycine and Mequitazine o
ver a 48 hour period. These two drugs are not considered to be predisp
osing factors for torsades de pointe despite the fact that they belong
to two families of drugs which can trigger this type of arrhythmia. T
he withdrawal of this treatment led to the complete regression of the
syncopal episodes with a follow-up of two years and a significant shor
tening of the initial QTc interval which remained, nevertheless, longe
r than normal. This case underlines the potential risks of drug associ
ations of these two families of drugs, especially in patients with the
congenital long Qt syndrome.